CaryHealth Appoints Andrew Bethel to Lead Direct-to-Patient Commercialization
At CaryHealth, we are committed to transforming how therapies reach and support patients. Today, we are proud to share a significant leadership milestone that furthers this mission: the appointment of Andrew Bethel as Executive Vice President of Direct-to-Patient (DTP) Commercialization.
Strategic Investment in the DTP Market
With the DTP market at a defining inflection point, CaryHealth is making strategic investments across its structure and operations. These efforts ensure pharmaceutical manufacturers have the tools and capabilities to deliver more connected, seamless patient experiences that improve adherence, engagement, and outcomes.
In this new role, Andrew will lead CaryHealth’s DTP Commercialization strategy and partnerships, driving the company’s next phase of growth in the direct-to-patient market.
Expertise in Scaling Healthcare Transformation
Andrew joins the leadership team with deep expertise spanning pharmacy operations, supply chain management, and healthcare transformation. As an embedded consultant, he played a pivotal role in building, launching, and scaling the DTP program for the leading GLP-1 from one of the world’s largest pharmaceutical manufacturers.
He was also instrumental in advancing the pharmacy vertical from concept to deployment and orchestrating operations across multiple fulfillment partners. His background brings a broad, practical perspective on how to build and scale programs that simplify the patient journey.
A Vision for Connected Care
“I’ve always been passionate about digital health and the positive impact it can bring to patients,” said Bethel. “I’m thrilled to help build on the foundation that the team has already established and expand our DTP strategy to create a better, more connected journey for patients and manufacturers.”
Areo Nazari, CEO and Co-Founder of CaryHealth, noted that the shift toward direct-to-patient care represents one of the most important opportunities the industry has seen in years.
“Manufacturers need partners who can unify the infrastructure, technology, and operations required to deliver a seamless experience for patients,” said Nazari. “Andrew’s background in building and scaling DTP programs will help us accelerate this work and strengthen our leadership in creating patient-centric access for our partners and the patients they serve.”
To learn more about CaryHealth’s DTP offering and how we are simplifying access to care, visit cary.health/direct-to-patient.
